Jan 25, 2021|

JD Health Won 2 Domestic Awards


by Hui Zhang

Lijun Xin, CEO of JD Health, was named as one of the top 10 people in China’s health industry, by China’s largest newspaper, People’s Daily, on Jan. 21. He was awarded the title for leading JD Health to accelerate telemedicine development, especially during the pandemic.

The list was announced at the 13th Health China Forum which was organized People’s Daily’s Health APP and Health Paper to reward organizations, individuals, projects and more in terms of industrial pioneering contribution, product/service quality, social responsibility and so on. The forum has been held for 12 consecutive years and has already grown to become one of China’s most influential forums focusing on the Chinese healthcare industry.

“JD Health will take ‘National Chief Health Manager’ as its mission and devote itself to becoming the most trustworthy health management enterprise,” said Xin.

“JD Health will focus on the four core business sectors of pharmaceutical supply chain, internet hospital, health management and smart medical care to create online and offline integrated medical services and make health management a daily routine for all.”

In addition, JD Health was named as the best innovative online healthcare platform of 2020 by iiMedia Research, a third-party data mining and analysis organization for new economic industries, on Jan. 19.

Telemedicine has been thrust into the spotlight since the outbreak of COVID-19 in China to cope with unprecedented demands for healthcare resources. During the fight against COVID-19, in addition to generous donations and efforts to source medical supplies, JD Health has offered free online medical consultation services and psychological care hotlines to people in China and abroad, and created a charity platform for chronic disease patients to maintain their drug supplies. During the pandemic, JD Health stepped up its effort in building online hospitals and has opened 16 specialized medical centers online, including a Respiratory Center as well as a Diabetes Center, to let more people access high-quality medical resources.

JD Health listed on the Hong Kong Stock Exchange (HKEX) on Dec. 8 with the ticker 6618.HK.